Last reviewed · How we verify

NCT06012825: PePA

Pediatric Physical Activity for Children With Cancer

Completed Last updated 21 November 2023
What this trial tests

trial testing Physical Activity in Pediatric Cancer in 12 participants. Completed in 12 May 2023.

Timeline
1 January 2022
Primary endpoint
9 May 2023
12 May 2023

Quick facts

Lead sponsorUniversity of Hawaii
StatusCompleted
Study typeOBSERVATIONAL
Enrollment12
Start date1 January 2022
Primary completion9 May 2023
Estimated completion12 May 2023
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Hawaii

Who can join

Adults 5 to 18, any sex, with Pediatric Cancer or Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this pilot study is to test the feasibility and participant adherence (pediatric patients diagnosed with childhood cancer) to a virtual, 12-week physical activity program. The aims of this project are to: 1. Determine the feasibility of administering the program and patient acceptability. 2. Report program adherence and completion rates. 3. Explore trends on the impact of a virtual PA intervention on psychosocial health and physical fitness. Participants will undergo pre- and post-assessments including measurements of fitness, self-reported fatigue and depression symptoms, social support, and current amount of physical activity. Patients will then be invited to participate in two consecutive, 12-week virtual physical activity interventions with similar-aged peers (2x/week, 60 minutes/session) over 2 rounds.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Physical Activity

Trials testing the same drug.

Other recruiting trials for Pediatric Cancer

Currently open trials in the same condition.

Other University of Hawaii trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06012825.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing